ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,264Medicare Part D Prescriptions Filled, Including Refills

Rank: 186 out of 3593

$789K Total Retail Price of All Prescriptions

Rank: 234 out of 3593

585 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 585 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

29% of this provider’s 585 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,411 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
MELOXICAM 980 719 1 29
HYDROCODONE-ACETAMINOPHEN 836 549 S3 2 7
OMEPRAZOLE 598 461 3 5
LOVASTATIN 527 394 4 20
AMLODIPINE BESYLATE 523 399 5 3
CARVEDILOL 499 440 6 23
LEVOTHYROXINE SODIUM 483 404 7 4
LISINOPRIL 411 352 8 2
SIMVASTATIN 319 263 9 1
GLIMEPIRIDE 294 225 10 44
TRAMADOL HCL-ACETAMINOPHEN 293 226 11 147
METOPROLOL SUCCINATE 292 244 12 19
TRIAMTERENE-HYDROCHLOROTHIAZID 271 237 10 13 231
ZOLPIDEM TARTRATE 270 198 14 12
SERTRALINE HCL 246 203 15 28
METFORMIN HCL 245 162 16 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 240 143 17 26
RAMIPRIL 231 199 18 92
LOSARTAN-HYDROCHLOROTHIAZIDE 225 187 19 48
LOSARTAN POTASSIUM 215 180 20 14
FUROSEMIDE 214 178 21 9
METFORMIN HCL ER 214 173 21 67
MIRTAZAPINE 204 163 23 64
DOXAZOSIN MESYLATE 202 179 24 63
TRAMADOL HCL 191 155 25 17
GABAPENTIN 184 72 26 16
AZITHROMYCIN 175 109 27 34
MORPHINE SULFATE ER 162 50 S2 28 108
FLUOXETINE HCL 161 45 29 60
TRIAMTERENE-HCTZ 159 131 30 66
PANTOPRAZOLE SODIUM 145 111 31 45
OXYBUTYNIN CHLORIDE ER 143 134 32 175
TAMSULOSIN HCL 135 92 33 33
FAMOTIDINE 123 92 34 70
HYDROCHLOROTHIAZIDE 113 91 35 10
RANITIDINE HCL 113 67 35 27
NEXIUM 113 57 35 36
METHADONE HCL 113 43 S2 35 158
CIPROFLOXACIN HCL 111 78 39 52
ALLOPURINOL 111 84 39 35
CARISOPRODOL 110 14 R 41 97
CLOPIDOGREL 108 101 42 30
WARFARIN SODIUM 98 83 43 18
MECLIZINE HCL 95 82 44 96
PREDNISONE 95 77 44 49
DONEPEZIL HCL 94 75 46 31
ATENOLOL 91 46 47 11
ATORVASTATIN CALCIUM 90 68 48 15
VERAPAMIL ER 88 61 49 99
BUPROPION XL 86 63 50 243
ALPRAZOLAM 84 59 51 37
ALENDRONATE SODIUM 84 78 51 22
ESTRADIOL 83 62 R 53 174
NAMENDA 81 81 54 50
POTASSIUM CHLORIDE 77 66 55 24
FENOFIBRATE 76 51 56 39
PAROXETINE HCL 76 72 56 62
METOPROLOL TARTRATE 76 48 56 8
BACLOFEN 75 52 59 109
OXYBUTYNIN CHLORIDE 71 58 60 104
COMBIVENT 71 32 60 161
DIAZEPAM 70 33 62 252
ISOSORBIDE MONONITRATE ER 70 61 62 61
TRICOR 67 29 64 130
TRAZODONE HCL 66 41 65 53
TIZANIDINE HCL 66 49 65 120
CRESTOR 64 51 67 21
CARTIA XT 62 57 68 299
PLAVIX 59 54 69 42
DIGOXIN 59 25 69 58
CITALOPRAM HBR 57 33 71 25
DILTIAZEM 24HR CD 57 51 71 173
VENLAFAXINE HCL ER 55 28 73 178
FINASTERIDE 54 54 74 79
PROAIR HFA 54 34 74 54
THEOPHYLLINE ANHYDROUS 54 29 74 286
PRAVASTATIN SODIUM 53 43 77 13
METHOTREXATE 52 17 78 354
MISOPROSTOL 52 43 78 394
CYCLOBENZAPRINE HCL 52 24 R 78 72
DIOVAN 51 51 81 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.